echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nat Med: Febutinib in the treatment of chronic spontaneous urticaria refractory to H1 antihistamines

    Nat Med: Febutinib in the treatment of chronic spontaneous urticaria refractory to H1 antihistamines

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic spontaneous urticaria (CSU) is characterized by the development of wind masses, angioedema, or both without obvious external causes for more than six weeks


    Febutinib is an oral, potent, highly selective, and reversible BTK inhibitor, which may be effective in the treatment of CSU


    Recently, a research article was published in the top medical journal Nature Medicine.


    The primary endpoint of the study was the change from baseline to week 8 in the urticaria activity score over 7 days (UAS7)


    Compared with the placebo group in the 50 mg febutinib treatment group, the 200 mg twice a day and 150 mg febutinib treatment group once a day reached the primary end point, that is, the dose-dependent improvement of UAS7 at week 8


    Thus, these results support the potential therapeutic effect of BTK inhibitors in CSU refractory to antihistamines


    These results support the potential therapeutic effect of BTK inhibitors in CSU refractory to antihistamines


    Original source:

    Original source:

    Martin Metz,et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.